Radwan, Rotana M.
Bridges, John F. P.
Hertz, Daniel L.
Lustberg, Maryam B.
Vachhani, Hetal
Hickey Zacholski, Erin
Sheppard, Vanessa B.
Salgado, Teresa M.
Funding for this research was provided by:
American Cancer Society (Institutional Research Grant IRG-21-134-46, Institutional Research Grant IRG-21-134-46)
National Cancer Institute (NIH-NCI Cancer Center Support Grant P30 CA016059, NIH-NCI Cancer Center Support Grant P30 CA016059)
Article History
Received: 24 July 2024
Accepted: 29 April 2025
First Online: 10 May 2025
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Virginia Commonwealth University Institutional Review Board, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: The authors declare no competing interests relevant to the content of this article. Dr. Teresa M. Salgado received funding from Boehringer Ingelheim for diabetes-related research. Dr. John F.P. Bridges consults for Boehringer Ingelheim and Otsuka and Lundbeck, and holds an Innovation in Regulatory Science Award from the Burroughs Wellcome Fund, all of which are outside the scope of the submitted work.